Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.

NCT02225977 · clinicaltrials.gov ↗

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Gilenya

Sponsor

University of Southern California